Application of multivariate analysis to optimize function of cultured hepatocytes

Biotechnology Progress

Volumn 19, Issue 2, 2003, Pages 580-598

  Chan, Christina ^a   Hwang, Daehee ^b   Stephanopoulos, Gregory N ^b   Yarmush, Martin L ^c   Stephanopoulos, George ^b  

^a Michigan State University   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; METABOLISM; PLASMAS; UREA;

BIOARTIFICIAL LIVER (BAL); METABOLIC FLUX ANALYSIS (MFA);

CELL CULTURE;

ALGORITHMS; ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COMPUTERS; CULTURE MEDIA, CONDITIONED; FEMALE; HEPATOCYTES; INSULIN; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MULTIENZYME COMPLEXES; MULTIVARIATE ANALYSIS; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; TRIGLYCERIDES; UREA;

ANIMALIA; MARTES PENNANTI;

EID: 0037357613     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp025660h     Document Type: Article

References (40)

1. OPTN. Adapted from UNOS OPTN data as of March 2002.
2. Hoofnagle, J. H.; Carithers, R. L. J.; Shapiro, C.; Ascher, N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995, 21-240.
3. Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaou, T. W.; Shackleton, C. R.; Rozga, J.; Solomon, B.; Demetriou, A. A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 1997, 225, 484-491.
4. Yarmush, M. L.; Dunn, J. C.; Tompkins, R. G. Assessment of artificial liver support technology. Cell Transplant 1992, 1, 323-341.
5. Nyberg, S. L.; Misra, S. P. Hepatocyte liver-assist systems - a clinical update. Mayo Clin, Proc. 1998, 73, 765-771.
6. Chan, C.; Berthiaume, F.; Washizu, J.; Toner, M.; Yarmush, M. L. Metabolic pre-conditioning of cultured cells in physiological levels of insulin: generating resistance to the lipid accumulating effects of plasma in hepatocytes. Biotechnol. Bioeng. 2002, 78, 753-760.
7. Matthew, H. W. T.; Sternberg, J.; Stefanovich, P.; Morgan, J. R.; Toner, M.; Tompkins, R. G.; Yarmush, M. L. Effects of plasma exposure on cultured hepatocytes: implications for bioartificial liver support. Biotechnol. Bioeng. 1996, 51, 100-111.
8. Uchino, J.; H. Matsue, Takahashi, M.; Nakajima, Y.; Matsushita, M.; Hamada, T.; Hashimura, E. A hybrid artificial liver system. Function of cultured monolayer pig hepatocytes in plasma from hepatic failure patients. ASAIO Trans. 1991, 37, M337-338.
9. Washizu, J.; Chan, C.; Berthiaume, F.; Tompkins, R. G.; Toner, M.; Yarmush, M. L. Amino Acid Supplementation Improves Cell-Specific Functions of the Rat Hepatocytes Exposed to Human Plasma. Tissue Eng. 2000, 6, 497-504.
10. Washizu, J.; Berthiaume, F.; Chan, C.; Tompkins, R. G.; Toner, M.; Yarmush, M. L. Optimization of rat hepatocyte culture in citrated human plasma. J. Surg. Res. 2000, 93, 237-246.
11. 13C isotopomer model for estimation of anaplerotic substrate oxidation via acetyl-CoA. Am. J. Physiol. 1996, 271, E788-E799.
12. Jones, J. G.; Carvalho, R. A.; Franco, B.; Sherry, A. D.; Malloy, C. R. Measurement of hepatic glucose output, Krebs cycle, and gluconeogenic fluxes by NMR analysis of a single plasma glucose sample. Anal. Biochem. 1998, 263, 39-45.
13. 13C] glucose in rats. J. Biol. Chem. 1989, 264, 12994-13001.
14. 13C] glucose. Proc. Natl. Acad. Sci. 1991, 88, 2103-2107.
15. Large, V.; Brunengraber, H.; Odeon, M.; Beylot, M. Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis. Am. J. Physiol. 1997, 272, E51-E58.
16. Yarmush, D. M.; MacDonald, A. D.; Foy, B. D.; Berthiaume, F.; Tompkins, R. G.; Yarmush, M. L. Cutaneous burn injury alters relative tricarboxylic acid cycle fluxes in rat liver. J. Burn Care Rehabil. 1999, 20, 292-302.
17. Lee, K.; Berthiaume, F.; Stephanopoulos, G. N.; Yarmush, D. M.; Yarmush, M. L. Metabolic flux analysis of post-burn hepatic hypermetabolism. Metab. Eng. 2000, 2, 312-327.
18. Arai, K.; Lee, K.; Berthiaume, F.; Tompkins, R. G.; Yarmush, M. L. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology 2001, 34, 360-371.
19. Chan, C.; Berthiaume, F.; Lee, K.; Yarmush, M. L. Metabolic flux analysis of cultured hepatocytes exposed to plasma. Biotechnol. Bioeng. 2002, 81, 33-49.
20. Chan, C.; Berthiaume, F.; Lee, K.; Yarmush, M. L. Effect of hormones on liver-specific function and lipid accumulation of hepatocytes during plasma exposure analyzed by metabolic flux analysis. Metab. Eng. 2002, in press.
21. Nguyen, D. V.; Rocke, D. M. Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 2002, 18, 39-50.
22. Dudoit, S.; Fridlyand, J.; Speed, T. P. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc. 2000, (to appear), Technical Report, 576.
23. Ball, G.; Mian, S.; Holding, F.; Allibone, R. O.; Lowe, J.; Ali, S.; Li, G.; McCardle, S.; Ellis, I. O.; Creaser, C.; Rees, R. C. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 2002, 18, 395-404.
24. Hwang, D. et al. Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics 2002, in press.
25. Seglen, P. O. Preparation of isolated rat liver cells. Methods Biol. 1976, 13, 29-83.
26. Dunn, J. C.; Tompkins, R. G.; Yarmush, M. L. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 1991, 7, 237-245.
27. Stephanopoulos, G. et al. Mapping physiological states from microarray expression measurements. Bioinformatics 2002, in press.
28. Rapoport, S. I., Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease. Int. Psychogeriatr. 1997, 9S1, 229-235; discussion 247-252.
29. Mariash, C. N.; Burmeister, L. A. Human lymphocyte messenger RNA activity profiles in type I and type II diabetes: a tool for classification of metabolic disease. J. Lab. Clin. Med. 1988, 112, 627-633.
30. Dillon, W. R.; Goldstein, M. Multivariate Analysis; Wiley: New York, 1984.
31. Baffi, G.; Martin, E. B.; Morris, A. J. Nonlinear projection to latent structures revisited: the quadratic PLS algorithm. Comput. Chem. Eng. 1999, 23, 395-411.
32. MacGregor, J. F.; Jaeckle, C.; Kiparissides, C.; Koutoudi, M. Process monitoring and diagnosis by multiblock PLS methods. AIChE J. 1994, 40, 826-838.
33. Geladi, P.; Kowalski, B. P. Partial least-squares regression: a tutorial. Anal. Chim. Acta 1986, 185, 1.
34. Wise, B. M.; Gallagher, N. B. PLS toolbox Version 2.1 User's guide; Eigenvector Research, Inc., 1997.
35. SAS/STAT User's Guide, 4th ed.; SAS Institute Inc., Cray, NC, 1989.
36. PLS toolbox Version 1.5.3 User's guide, 1997.
37. Simca-P user's guide: http://www.umetrics.com/download/SIMCA-P/simcapplus10ug.pdf
38. Tsoukalas, L. H.; Uhrig, R. E. Fuzzy and Neural Approaches in Engineering, John Wiley & Sons: New York, 1997.
39. Holter, N. S.; Mitra, M.; Maritan, A.; Cieplak, M.; Banavar, J. R.; Fedoroff, N. V. Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 8409-8414.
40. Johnson, R. A.; Wichern, D. W. Applied Multivariate Statistical Analysis, 5th ed.; McDonald, Q., ed., Prentice Hall: New York, 2002; Chapter 11.